Condition: Colorectal Cancer · Adenomatous Polyps · Adenoma · Sponsor: Zhejiang University
The primary objective of the study is to screen multi-omics markers in blood samples and construct a prediction model for CRC based on liquid biopsy, and we will further optimize the prediction model by validating its clinical performance externally.
This description comes directly from the study's public registry record.
Kefeng Ding, MD · 86-571-87784827 · dingkefeng@zju.edu.cn
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Zhejiang University | Hangzhou, Zhejiang, China | Recruiting |
| Sun Yat-Sen University Cancer Hospital | Guangzhou, China | Recruiting |
| Yunnan cancer hospital | Kunming, China | Recruiting |
| Jiangsu province hospital | Nanjing, China | Recruiting |
| The first affiliated hospital of Xi'an Jiaotong University | Xi'an, China | Recruiting |
| Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University | Zhengzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06220617